Aethlon Medical Inc

Research Aethlon Medical Inc (AEMD) on Bullrun: market cap USD 753.84K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 753.84K.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2026n/a-USD 7.15M-USD 7.00Mn/a-10.61USD 5.03MUSD 336.72KUSD 4.89M
FY2025USD 0-USD 13.39M-USD 7.65Mn/a-8.58USD 5.50MUSD 417.52KUSD 5.12M
FY2024USD 0-USD 12.21M-USD 10.38Mn/a-38.87USD 5.44MUSD 724.85KUSD 5.77M
FY2023USD 574.25K-USD 12.03M-USD 11.45Mn/a-5.86USD 14.53MUSD 1.01MUSD 15.06M
FY2022USD 294.17K-USD 10.42M-USD 10.12Mn/a-0.71USD 17.07MUSD 704.05KUSD 16.99M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 753.84Kn/an/an/a
20252025-12-31USD 2.69Mn/an/an/a
20242024-12-31USD 12.03Mn/an/an/a
20232023-12-29USD 5.47Mn/an/an/a
20222022-12-30USD 6.43Mn/an/an/a
20212021-12-31USD 28.72Mn/an/an/a

About Aethlon Medical Inc

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Aethlon Medical Inc's market cap?

Aethlon Medical Inc's market capitalization is USD 753.84K.

What does Aethlon Medical Inc do?

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.